The role of 11β-hydroxysteroid dehydrogenase in the pathogenesis of hypertension

被引:36
作者
van Uum, SHM
Hermus, ARMM
Smits, P
Thien, T
Lenders, JWM
机构
[1] Univ Nijmegen, St Radboud Univ Hosp, Dept Med, Div Gen Internal Med, NL-6500 HB Nijmegen, Netherlands
[2] Univ Nijmegen, Dept Med, Div Endocrinol, NL-6500 HB Nijmegen, Netherlands
[3] Univ Nijmegen, Dept Pharmacol, NL-6500 HB Nijmegen, Netherlands
关键词
11 beta-hydroxysteroid dehydrogenase; hypertension; glycyrrhetinic acid; licorice; AME-syndrome; cortisol; aldosterone;
D O I
10.1016/S0008-6363(97)00299-X
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The two 11 beta-hydroxysteroid dehydrogenase (11 beta-HSD) isozymes catalyze the interconversion of cortisol and cortisone. Type 1 11 beta-HSD (11 beta-HSD1) has bidirectional activity, while type 2 11 beta-HSD (11 beta-HSD2) mainly converts cortisol into cortisone. Of these two hormones only cortisol has affinity to mineralocorticoid receptors (MRs) and thus induces mineralocorticoid effects. A normal activity of 11 beta-HSD2 is crucial for prevention of mineralocorticoid activity of cortisol. Absent or decreased 11 beta-HSD2 activity results in cortisol-mediated hypermineralocorticoid hypertension. In several hypertensive syndromes a decreased 11 beta-HSD2 activity has been described as the pathogenetic mechanism of the increased blood pressure. In the apparent mineralocorticoid excess (AME) syndrome type 1, absence of 11 beta-HSD, activity is caused by mutations in the gene coding for 11 beta-HSD2, In licorice-induced hypertension glycyrrhetinic acid, the active substituent of licorice, inhibits 11 beta-HSD2 resulting in an acquired hypermineralocorticoid state. 11 beta-HSD2 activity is not decreased in glucocorticoid hypertension (Cushing's syndrome). In essential hypertension some evidence for decreased systemic and skin activity of 11 beta-HSD1 and/or 11 beta-HSD2 has been found, while renal activity of both isozymes appears to be normal. 11 beta-HSD2 activity is also present in cardiovascular myocytes of humans and dogs, and inhibition of 11 beta-HSD potentiates the vascular response to catecholamines. Although MRs in the central nervous system have been incriminated in the pathogenesis of mineralocorticoid hypertension, a pathophysiological role for 11 beta-HSD2 has not yet been described. Finally, in the placenta 11 beta-HSD2 reduces fetal exposure to maternal glucocorticoids and a decreased activity of this isozyme may result in low birth weight and increased risk of high blood pressure at adult age. (C) 1998 Elsevier Science B.V.
引用
收藏
页码:16 / 24
页数:9
相关论文
共 107 条
[1]  
AGARWAL AK, 1994, J BIOL CHEM, V269, P25959
[2]   EXPRESSION OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE USING RECOMBINANT VACCINIA VIRUS [J].
AGARWAL, AK ;
TUSIELUNA, MT ;
MONDER, C ;
WHITE, PC .
MOLECULAR ENDOCRINOLOGY, 1990, 4 (12) :1827-1832
[3]  
AGARWAL AK, 1989, J BIOL CHEM, V264, P18939
[4]   CLONING AND TISSUE DISTRIBUTION OF THE HUMAN 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE-2 ENZYME [J].
ALBISTON, AL ;
OBEYESEKERE, VR ;
SMITH, RE ;
KROZOWSKI, ZS .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1994, 105 (02) :R11-R17
[5]   CORTICOID RECEPTORS IN RAT-BRAIN - EVIDENCE FOR AN ALDOSTERONE RECEPTOR [J].
ANDERSON, NS ;
FANESTIL, DD .
ENDOCRINOLOGY, 1976, 98 (03) :676-684
[6]   CLONING OF HUMAN MINERALOCORTICOID RECEPTOR COMPLEMENTARY-DNA - STRUCTURAL AND FUNCTIONAL KINSHIP WITH THE GLUCOCORTICOID RECEPTOR [J].
ARRIZA, JL ;
WEINBERGER, C ;
CERELLI, G ;
GLASER, TM ;
HANDELIN, BL ;
HOUSMAN, DE ;
EVANS, RM .
SCIENCE, 1987, 237 (4812) :268-275
[7]   FETAL AND PLACENTAL SIZE AND RISK OF HYPERTENSION IN ADULT LIFE [J].
BARKER, DJP ;
BULL, AR ;
OSMOND, C ;
SIMMONDS, SJ .
BRITISH MEDICAL JOURNAL, 1990, 301 (6746) :259-262
[8]  
BENEDIKTSSON, 1993, LANCET, V341, P572
[9]   GLUCOCORTICOID EXPOSURE INUTERO - NEW MODEL FOR ADULT HYPERTENSION [J].
BENEDIKTSSON, R ;
LINDSAY, RS ;
NOBLE, J ;
SECKL, JR ;
EDWARDS, CRW .
LANCET, 1993, 341 (8841) :339-341
[10]  
BENEDIKTSSON R, 1994, J HUM HYPERTENS, V8, P371